1
Nov 20 (Reuters) – Natco Pharma Ltd: * NATCO PHARMA – RECEIVES EIR FROM U.S. FDA FOR FDF UNIT * NATCO PHARMA – COMPANY RECEIVED 4 OBSERVATIONS IN FORM-483 AT FDA INSPECTION CONCLUSION * NATCO PHARMA –
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)